Condition
Acute Myeloid Leukemia With t(8 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Acute Myeloid Leukemia With t(8 clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Avapritinib with standard chemotherapy for newly diagnosed KIT‑mutant CBF‑AML
This will test whether adding avapritinib to standard induction and consolidation therapies helps adults newly diagnosed with KIT‑mutated core‑binding factor AML achieve deeper remissions and live longer.
-
Combination chemotherapy for newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome
This study is testing a mix of chemotherapy drugs to see if they can help people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome achieve remission and live longer.
Related topics
Quick answers
How many Acute Myeloid Leukemia With t(8 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.